Meet STING: Scientists identify natural immune-boosting protein that could promote anti-cancer immunity
STING stands for Stimulator of Interferon Genes; it stimulates the immune system whenever there is a viral or cancerous invader in the body.
Cancer is a complex disease which requires a multi-directional approach for its treatment. Oncologists are still working on finding more innovative approaches to tackle cancer in an effective manner. However, as per a recent article published in the journal Science on 21st August 2020, scientists have found a natural immune-boosting protein called STING, which can produce anti-tumour immunity in the body.
What is STING?
STING stands for Stimulator of Interferon Genes; it stimulates the immune system whenever there is a viral or cancerous invader in the body. STING is a protein which is made up of 379 amino acids and is found in various endothelial cells, epithelial cells, haematopoietic cells, T cells, macrophages and even dendritic cells (antigen-presenting cells).
STING acts as a molecule which controls the transcription of various genes, including the genes of the host defence system. The host defence genes include the genes that produce immune cells, like type I interferons (IFNs) and pro-inflammatory cytokines, whenever they sense any abnormal DNA in the cells. This abnormal DNA is usually of the microorganisms (any bacteria or virus) which try to invade the cells.
How STING would help treat cancer?
In various studies, scientists have mentioned that STING promotes anti-tumour immunity. Usually, STING activates in the presence of an abnormal DNA in the blood. But the problem is that this DNA does not stay in the blood for long, so the activation of STING is short-lived.
Recently, scientists at Scripps Research claimed that they have found a set of small diverse molecules which can help in the activation of STING.
Dr Luke L Lairson along with his fellow researchers developed a STING-activator, called SR-717, which activated the STING protein in the same way as its natural activators in the body. When the scientists used x-ray crystallography to view the interaction of the activator on cellular levels, they found that both SR-717 and a natural activator bind to the same site on the STING protein.
Both these synthetic and natural activators produced the same change in the shape of the protein.
The scientists further tested SR-717 on a group of mice with aggressive melanoma who were given the STING-activator orally. The results showed that SR-717 suppressed the growth of the tumour, prevented its spread in the body (metastasis) and also boosted the immune system’s anti-tumour defences which include CD8+ T cells and natural killer cells.
The scientists are still studying the STING-activator to form a new anti-cancer treatment which can either be used alone or in combination with other treatment options.
Furthermore, scientists believe that with the use of a systemic STING-activating molecule, scientists would not only be able to use it for the treatment of cancer and other infectious diseases but would also allow the researchers to study more about the STING-dependent anti-tumour immunity.
For more information, read our article on Cancer.
Health articles in Firstpost are written by myUpchar.com, India’s first and biggest resource for verified medical information. At myUpchar, researchers and journalists work with doctors to bring you information on all things health.
The information provided here is intended to provide free education about certain medical conditions and certain possible treatment. It is not a substitute for examination, diagnosis, treatment, and medical care provided by a licensed and qualified health professional. If you believe you, your child or someone you know suffers from the conditions described herein, please see your health care provider immediately. Do not attempt to treat yourself, your child, or anyone else without proper medical supervision. You acknowledge and agree that neither myUpchar nor firstpost is liable for any loss or damage which may be incurred by you as a result of the information provided here, or as a result of any reliance placed by you on the completeness, accuracy or existence of any information provided herein.
Pakistan’s former president Pervez Musharraf died on Sunday in Dubai after suffering from amyloidosis. Affecting about 4,000 people in the US each year, this rare illness is caused by a build-up of an abnormal protein called amyloid in organs and tissues
The causes of delay in diagnosis in India range from patients ignoring the symptoms, delay of up to three months in seeking professional help, lack of access to specialised facilities, stigma attached to cancer and financial constraints